Clinical Trial Update: Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating reduced fluence parameters for photocoagulation in proliferative diabetic retinopathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Proliferative Diabetic Retinopathy | Phase 4 | Status: TERMINATED